Brussels, Belgium

Nathalie Wauthoz

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Université Libre De Bruxelles, Katholieke Universiteit Leuven. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nathalie Wauthoz. Retrieved from https://idiyas.com/inventor/nathalie-wauthoz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Tournai, BE (2019)
  • Brussels, BE (2021)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Nathalie Wauthoz - Pioneering Innovations in Pharmaceutical Formulations

Introduction

Nathalie Wauthoz, an accomplished inventor based in Brussels, Belgium, has made significant contributions in the field of pharmaceutical formulations. With a total of three patents to her name, she has demonstrated her commitment to advancing medical therapies, particularly in the treatment of lung conditions and central nervous tumors.

Latest Patents

Nathalie's latest patents showcase groundbreaking advancements in drug delivery systems. The first patent focuses on a dry powder inhalation formulation designed for therapeutic treatment of the lungs. This innovative formulation includes at least one active pharmaceutical ingredient (API) combined with a lipid matrix that contains triglycerides selected from a specific group, thereby enhancing the efficacy of inhaled medications.

The second patent pertains to the treatment of central nervous tumors. This invention revolves around a new formulation that encapsulates siRNA within nanoparticles, utilizing RNA interference technology to silence the galectin-1 gene, which plays a role in tumor progression. This particular formulation is strategic for addressing glioblastoma multiforme (GBM), a challenging type of brain cancer.

Career Highlights

Nathalie has had a fruitful career, collaborating with esteemed institutions such as the Université Libre De Bruxelles and Katholieke Universiteit Leuven. Her work at these universities has allowed her to push the boundaries of pharmaceutical science and contribute to significant research findings, particularly in innovative treatment modalities.

Collaborations

Throughout her career, Nathalie has worked alongside notable colleagues, including Karim Amighi and Steven De Vleeschouwer. Their joint efforts have played a crucial role in developing cutting-edge solutions for medical challenges in the field of pharmaceuticals.

Conclusion

Nathalie Wauthoz stands out as an innovative thinker and dedicated inventor in the pharmaceutical industry. Her inventions reflect her commitment to improving healthcare outcomes through advanced therapeutic formulations. With her ongoing research and development, she continues to inspire future generations of inventors and scientists in the pursuit of medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…